Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Myeloid Leukemia (AML) · Chronic Myeloid Leukemia · Myelodysplastic Syndromes (MDS) · Myeloprolipherative Neoplsm · Atypical Chronic Myeloid Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations